>> VPHM/ Another HCV blowup...Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
Can someone provide a one-paragraph update of the emerging HCV therapeutic landscape? For example - which new HCV drugs are likely to be approved in the next 3-5 years and maybe a sentence or two about each?